Alliance Pharma (APH)

Sector:

Pharma and Biotech

Index:

FTSE AIM 50

36.40p
   
  • Change Today:
    -0.35p
  • 52 Week High: 71.80p
  • 52 Week Low: 34.50p
  • Currency: UK Pounds
  • Shares Issued: 540.40m
  • Volume: 114
  • Market Cap: £196.71m
  • RiskGrade: 119

Company Description

Peerless Technology is a shell company co-founded by Peter Wilkinson, the serial internet entrepreneur who founded Freeserve.

IPO Details

Issue Date 22-Nov-2001 Prospectus n/a
Issue Price 20.00p Lead Broker Numis Securities
Market Cap £3.00m Contact Tel 0207 776 1500
Method Placing    
Sector Investment companies    
Market Aim    
Amount Raised £2.00m    

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

Alliance Pharma Market Data

Currency UK Pounds
Share Price 36.40p
Change Today -0.35p
% Change -0.95 %
52 Week High 71.80p
52 Week Low 34.50p
Volume 114
Shares Issued 540.40m
Market Cap £196.71m
RiskGrade 119

Alliance Pharma Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
82.05% above the market average82.05% above the market average82.05% above the market average82.05% above the market average82.05% above the market average
100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average
Price Trend
65.04% below the market average65.04% below the market average65.04% below the market average65.04% below the market average65.04% below the market average
15.79% above the sector average15.79% above the sector average15.79% above the sector average15.79% above the sector average15.79% above the sector average
Income
4.26% above the market average4.26% above the market average4.26% above the market average4.26% above the market average4.26% above the market average
25.00% above the sector average25.00% above the sector average25.00% above the sector average25.00% above the sector average25.00% above the sector average
Growth
88.65% below the market average88.65% below the market average88.65% below the market average88.65% below the market average88.65% below the market average
83.78% below the sector average83.78% below the sector average83.78% below the sector average83.78% below the sector average83.78% below the sector average

What The Brokers Say

Strong Buy 4
Buy 0
Neutral 3
Sell 0
Strong Sell 0
Total 7
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Alliance Pharma Dividends

  Latest Previous
  Final Interim
Ex-Div 22-Jun-23 22-Dec-22
Paid 18-Jul-23 19-Jan-23
Amount 1.18p 0.59p

Trades for 19-Apr-2024

Time Volume / Share Price
08:01 1 @ 36.40p
08:00 100 @ 36.05p
08:00 8 @ 36.40p
08:00 5 @ 36.40p

Alliance Pharma Key Personnel

CEO Peter Butterfield
CFO Andrew Franklin
Chair Camillo Pane

Top of Page